Annual Healthcare Symposium

This year's theme: Innovation and Patient Access After the Inflation Reduction Act

18 Apr
Price: FREE

1 Washington Place Newark, NJ, 07102 | Bove Auditorium & 2nd Floor Lounge

The Inflation Reduction Act (IRA) of 2022 brought a tremendous change in the Medicare Part D Prescription Drug benefit operation and coverage. The Academia and the industry has been analyzing the impact of the IRA on the Bio Pharmaceutical R&D, Access to drugs by the elderly population in the USA, impact on drugs approvals, and employment. This will have a spillover effect on the prescription drugs in the private market. The symposium will bring together industry experts, academia and the patients advocacy groups to discuss in front of our students, and faculty, and give them an opportunity to interact with the experts in the form of Q&A session. The symposium is open to all students, faculty, and the industry executives. It is a free event.

Register Today



8:30 - 9:00 AMRegistration & Networking Breakfast
9:00 - 9:10 AM


Mahmud Hassan
Director, The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues

9:10 - 9:20 AM

Welcome Address

Lei Lei, Ph.D.
Dean, Rutgers Business School

9:20 - 9:30 AM


Michael Lerner, JD
Chairman, Lener Center Board Partner, and Chair, Life Sciences Group Lowenstein Sandler LLP

9:30 - 9:40 AM

Life and Legacy of Irwin Lerner

Ken Berkowitz
Former Assistant General Counsel, Vice  President, Public Affairs, Drug Regulatory Affairs and Drug Safety, Hoffmann-La Roche, Inc

9:40 - 10:05 AM

Q&A 10:05 - 10:35 AM

Presentation and Q&A

Paul Hastings
President & CEO, Nkarta Therapeutics Inc

10:35 - 10:50 AMBreak

10:50 - 11:50 AM

Q&A 11:50 - 12:20 PM

Innovation and Patient Access After the Inflation Reduction Act
Leadership Panel Discussion and Q&A

Panel Moderator
Richard Bagger, JD
Former Executive Vice President, Corporate Affairs and Market Access, Celgene
Adjunct Faculty Member, Eagelton Institute, Rutgers University    

Panel Members
Neal Masia, PhD
Co-Founder and Chief Executive Officer, EntityRisk, Adjunct Professor Columbia University

John M. O'Brien, PharmD, MPH
President and CEO of the National Pharmaceutical Council

Patricia J. Goldsmith
Former Chief Executive, Officer of CancerCare

Amadou Diarra Ph.D
Former Senior Vice President of Global Policy, Patient Advocacy & Government Affairs, Bristol-Myers Squibb

12:20 - 1:20 PMNetworking Luncheon

Register Today


If you have any further questions, please contact Mahmud Hassan at


This event is free.